Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, overpri
Target Price
The average target price of SUS.ST is 66 and suggests 131% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell